CRO市場分析及管理知識規劃(PPT 13頁)

CRO市場分析及管理知識規劃(PPT 13頁)簡介：

2006
As one of top 30 international drug discovery CRO companies
As one of top 3 Chinese drug discovery CRO companies (Medicilon, Bridge and Wuxi were featured)
(A CHA report) 2006
As one of top 5 CRO companies in China
Wall Street Reporter Telephone Interview (Sept. 18, 2006)
Chemical & Engineering News, SPRUNG FROM MEDICHEM Dec. 20, 2004
Chemical & Engineering News, CHINESE INDUSTRIAL PARKS UP THE ANTE, Oct. 31, 2006
Business Documentaries.com - “Shanghai High-Tech Future” Nov. 27, 2006
Chemical & Engineering News, CHINA STRIDES TOWARD GLOBAL PHARMA ROLE, March 12, 2007
Chemical & Engineering News, MEDICILON STRIVES TO KEEP THE PACE, JUNE 9, 2008
Pharmaceutical Executive, Media Center Interviews, Dec, 2009.

據美國PHYD最新出爐的《亞洲地區醫藥研發外包發展動態報告》顯示，2008年中國醫藥研發外包（contractResearchOrganization簡稱CRO）市場已經上升到約2.6億美元，較之2005年2500萬美元的市場足足增長了 10餘倍，預計到2010年可增長至4.3億美元。不難看出，製藥工業正在加速減少傳統的內部研發力量，增加研發外包的比例。目前，中國已經超過印度成為亞洲研發外包首選地。
Based on Source: Frost & Sullivan. 2005年全球CRO總金額達到163億美元，預計2010年將達到360億美元的規模

..............................